Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone in Congenital Heart Disease
NCT01971593Phase 4Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Aug 2013
- Primary completion
- Mar 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of eplerenone in tetralogy of Fallot (TOF), transposition of the great vessels (TGV), single ventricle heart defect, sponsored by Washington University School of Medicine. Started Aug 2013; status: terminated.
02
Drugs
eplerenone
03
Conditions
tetralogy of Fallot (TOF)transposition of the great vessels (TGV)single ventricle heart defect
Beyond the preview
Go deeper on NCT01971593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01971593.